Answers are grounded in this paper and cite their sources.
Highlights differences in device regulation between the US and EU regarding the Watchman device and emphasizes the need for rigorous post-market monitoring.
Examination of the FDA's review of the Watchman Left Atrial Appendage Closure System clarifies differences in device regulation between the United States and the European Union and highlights the urgency of monitoring devices in a coordinated and rigorous manner.
No takes yet. Share an insight, caveat, or question.
Kramer et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: